{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:56:55Z","timestamp":1762876615356,"version":"3.45.0"},"reference-count":27,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR127385"],"award-info":[{"award-number":["NIHR127385"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Orthostatic hypotension is a significant drop in blood pressure upon standing upright. It is very common and can result in symptoms such as postural dizziness, fainting and falls. Within the United Kingdom National Health Service, there are three principal treatments: non-drug therapies, and two medications \u2013 fludrocortisone or midodrine. Despite this we do not know which treatments are the most effective, nor whether they are cost-effective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evaluate the feasibility of a randomised trial to evaluate the clinical and cost-effectiveness of fludrocortisone and midodrine in comparison to non-drug therapies for the treatment of orthostatic hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-3\">\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A 10-month pilot of a pragmatic, open-label, randomised, prospective, superiority, multiarm, multistage clinical trial. The pilot evaluated recruitment, attrition, crossover and quality of outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-4\">\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Falls and Syncope, Movement Disorder, Geriatrics, and Cardiology clinics in United Kingdom National Health Service secondary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-5\">\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults with symptomatic orthostatic hypotension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-6\">\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Control: Non-drug therapies (conservative management). Interventions: Conservative management plus fludrocortisone (50\u2013400 mcg daily) or conservative management plus midodrine (5\u201330 mg daily).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-7\">\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Recruitment: Target was 40\u201364 participants from 14 sites. Attrition target: \u2264\u200515% participants withdraw before the primary end point. Crossover: To determine the rates of crossover between intervention arms. Outcome data: Assess the quality and completeness of outcomes. Other important outcomes included feedback via questionnaire and interview from sites and participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two hundred and eighty-two patients were screened for eligibility during the pilot; of these, 13 were recruited from 4 of 9 open sites. Current or recent use of one of the study medications accounted for 120 (52%) exclusions due to ineligibility. At the primary end point of 6 months, 10 of the 13 participants (77%) remained in the study. Of those, completion rates for primary and secondary outcomes were 100%, except for the falls diaries, which was 60%.<\/jats:p>\n                    <jats:p>Feedback from sites revealed that redeployment of clinical and research staff due to COVID-19 negatively impacted on site opening and screening for eligible participants. Adapting the protocol to make it more flexible for remote clinics and more pragmatic for clinical use did not improve recruitment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-9\">\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>The sample size is too small to provide a reliable estimate of attrition and crossover rates for future studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-10\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study was not feasible in its current design. COVID-19 had an impact on staffing and site opening, while the exclusion criteria limited recruitment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-11\">\n                    <jats:title>Future work<\/jats:title>\n                    <jats:p>To answer the research question, novel trial designs are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-12\">\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127385.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3310\/hgrw7249","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T04:44:46Z","timestamp":1736484286000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: CONFORM-OH pilot RCT and economic evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-3734","authenticated-orcid":true,"given":"Helen","family":"Mossop","sequence":"first","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6044-4674","authenticated-orcid":true,"given":"Sarah","family":"Al Ashmori","sequence":"additional","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-9568","authenticated-orcid":true,"given":"Tumi","family":"Sotire","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-1463","authenticated-orcid":true,"given":"Emma","family":"Clark","sequence":"additional","affiliation":[{"name":"Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2466-0268","authenticated-orcid":true,"given":"Gillian","family":"Watson","sequence":"additional","affiliation":[{"name":"Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-0990","authenticated-orcid":true,"given":"Miles","family":"Witham","sequence":"additional","affiliation":[{"name":"AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8574-8429","authenticated-orcid":true,"given":"Luke","family":"Vale","sequence":"additional","affiliation":[{"name":"Health Economics Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5961-124X","authenticated-orcid":true,"given":"Naomi","family":"McGregor","sequence":"additional","affiliation":[{"name":"Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-4223","authenticated-orcid":true,"given":"Julia","family":"Phillipson","sequence":"additional","affiliation":[{"name":"Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-126X","authenticated-orcid":true,"given":"James MS","family":"Wason","sequence":"additional","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-9163","authenticated-orcid":true,"given":"Alison J","family":"Yarnall","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University and Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-8551","authenticated-orcid":true,"given":"Helen","family":"Hancock","sequence":"additional","affiliation":[{"name":"Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-8124","authenticated-orcid":true,"given":"Rose Anne","family":"Kenny","sequence":"additional","affiliation":[{"name":"Medical Gerontology, School of Medicine, Trinity College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-3701","authenticated-orcid":true,"given":"James","family":"Frith","sequence":"additional","affiliation":[{"name":"Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"key2025111120073000_ref1-bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"key2025111120073000_ref2-bib2","doi-asserted-by":"crossref","first-page":"e8004","DOI":"10.1097\/MD.0000000000008004","article-title":"Prevalence, risk factors, and prognosis of orthostatic hypotension in diabetic patients: a systematic review and meta-analysis","volume":"96","author":"Zhou","year":"2017","journal-title":"Medicine"},{"key":"key2025111120073000_ref3-bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key2025111120073000_ref4-bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/gerona\/gly188","article-title":"The prevalence of orthostatic hypotension: a systematic review and meta-analysis","volume":"75","author":"Saedon","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key2025111120073000_ref5-bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.11.344","article-title":"Orthostatic hypotension in Parkinson disease: impact on health care utilization","volume":"47","author":"Merola","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"key2025111120073000_ref6-bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","article-title":"The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale","volume":"22","author":"Kaufmann","year":"2012","journal-title":"Clin Auton Res"},{"key":"key2025111120073000_ref7-bib7","first-page":"439","article-title":"A prospective study of the association between orthostatic hypotension and falls: definition matters","volume":"46","author":"McDonald","year":"2016","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref8-bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11136-019-02295-6","article-title":"Orthostatic hypotension and health-related quality of life among community-living older people in Korea","volume":"29","author":"Kim","year":"2020","journal-title":"Qual Life Res"},{"key":"key2025111120073000_ref9-bib9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/HJH.0000000000000235","article-title":"Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis","volume":"32","author":"Angelousi","year":"2014","journal-title":"J Hypertens"},{"key":"key2025111120073000_ref10-bib10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/eurheartj\/ehv093","article-title":"Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies","volume":"36","author":"Ricci","year":"2015","journal-title":"Eur Heart J"},{"key":"key2025111120073000_ref11-bib11","first-page":"168","article-title":"New Horizons in orthostatic hypotension","volume":"46","author":"Frith","year":"2017","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref14-bib14","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"key2025111120073000_ref15-bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ageing\/afs061","article-title":"Efficacy of treatments for orthostatic hypotension: a systematic review","volume":"41","author":"Logan","year":"2012","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref16-bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.apmr.2014.09.028","article-title":"Nonpharmacologic management of orthostatic hypotension: a systematic review","volume":"96","author":"Mills","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"key2025111120073000_ref17-bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ijcp.12122","article-title":"A systematic review of the pharmacological management of orthostatic hypotension","volume":"67","author":"Ong","year":"2013","journal-title":"Int J Clin Pract"},{"key":"key2025111120073000_ref18-bib18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","article-title":"Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Parsaik","year":"2013","journal-title":"J Gen Intern Med"},{"key":"key2025111120073000_ref19-bib19","doi-asserted-by":"crossref","first-page":"afac153","DOI":"10.1093\/ageing\/afac153","article-title":"Feasibility, reliability and safety of self-assessed orthostatic blood pressure at home","volume":"51","author":"Gibbon","year":"2022","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref20-bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/026921558700100409","article-title":"An extended activities of daily living scale for stroke patients","volume":"1","author":"Nouri","year":"1987","journal-title":"Clin Rehabil"},{"key":"key2025111120073000_ref21-bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ageing\/afu109","article-title":"Public and patient research priorities for orthostatic hypotension","volume":"43","author":"Frith","year":"2014","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref22-bib22","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S1473-3099(20)30791-X","article-title":"Personalised randomised controlled trial designs \u2013 a new paradigm to define optimal treatments for carbapenem-resistant infections","volume":"21","author":"Walker","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"key2025111120073000_ref23-bib23","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3399\/BJGP.2022.0111","article-title":"Incidence of postural hypotension recorded in UK general practice: an electronic health records study","volume":"73","author":"Bhanu","year":"2023","journal-title":"Br J Gen Pract"},{"key":"key2025111120073000_ref24-bib24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMoa2001500","article-title":"Screening and intervention to prevent falls and fractures in older people","volume":"383","author":"Lamb","year":"2020","journal-title":"N Engl J Med"},{"key":"key2025111120073000_ref25-bib25","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key2025111120073000_ref26-bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ageing\/afr115","article-title":"Improving recruitment of older people to research through good practice","volume":"40","author":"McMurdo","year":"2011","journal-title":"Age Ageing"},{"key":"key2025111120073000_ref27-bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"key":"key2025111120073000_ref28-bib28","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","article-title":"The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial","volume":"53","author":"Freeman","year":"1999","journal-title":"Neurology"},{"key":"key2025111120073000_ref29-bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/HGRW7249\/HGRW7249.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:44:10Z","timestamp":1762872250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/HGRW7249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["10.3310\/HGRW7249"],"URL":"https:\/\/doi.org\/10.3310\/hgrw7249","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"11-2019","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"03-2024","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"06-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}